ARTIFICIAL TEARS

ARTIFICIAL TEARS was reported 2615 times

ARTIFICIAL TEARS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EYE OPERATION COMPLICATION 19 0.1159
1 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 8 0.1000
2 DEAFNESS PERMANENT 16 0.0816
3 FUNGURIA 3 0.0811
4 BURKHOLDERIA TEST POSITIVE 7 0.0565
5 ENDOCRINE OPHTHALMOPATHY 48 0.0553
6 AUTOPHONY 4 0.0533
7 PUNCTAL PLUG INSERTION 3 0.0429
8 ANTI-THYROID ANTIBODY INCREASED 5 0.0397
9 PERSISTENT CORNEAL EPITHELIAL DEFECT 4 0.0339
10 CORNEAL STRIAE 2 0.0282
11 CHORIORETINAL FOLDS 2 0.0282
12 PERIORBITAL PAIN 23 0.0272
13 BASE EXCESS INCREASED 2 0.0225
14 CORNEAL INFILTRATES 6 0.0191
15 KERATITIS BACTERIAL 3 0.0184
16 EYELID PAIN 36 0.0177
17 CORNEAL EPITHELIUM DEFECT 10 0.0172
18 CORNEAL THINNING 4 0.0156
19 KERATITIS FUNGAL 3 0.0144
20 DERMATOCHALASIS 2 0.0136
21 KERATOCONJUNCTIVITIS SICCA 5 0.0136
22 VERY LOW DENSITY LIPOPROTEIN INCREASED 3 0.0135
23 IMPAIRED FASTING GLUCOSE 4 0.0131
24 TYPE V HYPERLIPIDAEMIA 6 0.0123
25 DEAFNESS NEUROSENSORY 38 0.0115
26 CORNEAL PERFORATION 7 0.0111
27 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
28 BORDERLINE GLAUCOMA 2 0.0108
29 EPIRETINAL MEMBRANE 3 0.0108
30 PRODUCT INFORMATION CONTENT COMPLAINT 3 0.0108
31 CERUMEN IMPACTION 9 0.0098
32 FOREIGN BODY SENSATION IN EYES 61 0.0096
33 CATARACT NUCLEAR 6 0.0090
34 CORNEAL OPACITY 12 0.0088
35 CORNEAL DEGENERATION 2 0.0083
36 CORNEAL NEOVASCULARISATION 2 0.0081
37 CORNEAL DEPOSITS 6 0.0081
38 CORNEAL SCAR 4 0.0080
39 KERATITIS 23 0.0076
40 CONJUNCTIVITIS VIRAL 2 0.0075
41 CORNEAL EROSION 4 0.0074
42 CHEMICAL BURNS OF EYE 2 0.0072
43 EYE INFECTION BACTERIAL 4 0.0072
44 EYE ULCER 4 0.0069
45 EUSTACHIAN TUBE DYSFUNCTION 4 0.0069
46 CORNEAL ABRASION 9 0.0066
47 EYE PAIN 365 0.0065
48 CORNEAL TRANSPLANT 5 0.0064
49 GROWTH OF EYELASHES 5 0.0063
50 DEVICE PROGRAMMING ERROR 2 0.0063
51 CORNEAL OEDEMA 14 0.0062
52 CORNEAL DISORDER 13 0.0059
53 SCLERAL HYPERAEMIA 4 0.0059
54 NEUROENDOCRINE CARCINOMA 4 0.0058
55 INTRAOCULAR PRESSURE DECREASED 3 0.0057
56 INSTILLATION SITE ERYTHEMA 3 0.0057
57 ABNORMAL SENSATION IN EYE 23 0.0053
58 OCULAR DISCOMFORT 60 0.0053
59 OPHTHALMIC HERPES SIMPLEX 3 0.0052
60 GRAFT COMPLICATION 3 0.0051
61 EYE BURNS 3 0.0051
62 MEAN PLATELET VOLUME INCREASED 3 0.0050
63 OPEN ANGLE GLAUCOMA 3 0.0049
64 ULCERATIVE KERATITIS 13 0.0047
65 THYROXINE FREE INCREASED 3 0.0047
66 CHOROIDAL NEOVASCULARISATION 4 0.0047
67 VITREOUS DETACHMENT 10 0.0046
68 DRY AGE-RELATED MACULAR DEGENERATION 5 0.0045
69 BLOOD ALBUMIN INCREASED 4 0.0045
70 KERATOPATHY 7 0.0044
71 EYE IRRITATION 254 0.0044
72 PUNCTATE KERATITIS 4 0.0044
73 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
74 BLOOD BICARBONATE INCREASED 2 0.0042
75 PHOTOPHOBIA 77 0.0041
76 BLEPHARITIS 15 0.0037
77 REACTION TO PRESERVATIVES 3 0.0037
78 BURSITIS INFECTIVE 2 0.0037
79 SUPERFICIAL INJURY OF EYE 4 0.0037
80 INSTILLATION SITE PAIN 9 0.0036
81 BLOOD PH INCREASED 2 0.0036
82 SOFT TISSUE DISORDER 4 0.0036
83 EYELID IRRITATION 9 0.0036
84 MEAN PLATELET VOLUME DECREASED 3 0.0036
85 VITREOUS OPACITIES 3 0.0036
86 CONJUNCTIVITIS ALLERGIC 5 0.0034
87 CONJUNCTIVAL HYPERAEMIA 12 0.0034
88 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
89 PRODUCT USE COMPLAINT 53 0.0034
90 ERYTHEMA OF EYELID 18 0.0033
91 ANAEMIA OF CHRONIC DISEASE 3 0.0033
92 ASTHENOPIA 18 0.0033
93 EYE ALLERGY 5 0.0032
94 NASAL ULCER 5 0.0031
95 FOREIGN BODY IN EYE 3 0.0031
96 CHALAZION 2 0.0031
97 EYELID MARGIN CRUSTING 9 0.0031
98 CHONDROCALCINOSIS 2 0.0031
99 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
100 EYELID DISORDER 7 0.0030
101 EYE COLOUR CHANGE 3 0.0029
102 CARBON DIOXIDE INCREASED 4 0.0029
103 EYE DISCHARGE 30 0.0029
104 LACRIMATION INCREASED 87 0.0029
105 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
106 HYDROCELE 3 0.0028
107 ANTERIOR CHAMBER CELL 2 0.0028
108 CERVICAL RADICULOPATHY 2 0.0028
109 EXOPHTHALMOS 6 0.0028
110 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
111 EYE INFLAMMATION 26 0.0027
112 BLOOD CHLORIDE DECREASED 7 0.0027
113 PHYSICAL DISABILITY 12 0.0027
114 ASTIGMATISM 4 0.0026
115 CARBON DIOXIDE DECREASED 3 0.0026
116 BLOOD SODIUM INCREASED 7 0.0026
117 MEAN CELL VOLUME DECREASED 4 0.0026
118 SWELLING OF EYELID 16 0.0025
119 OSTEOSCLEROSIS 4 0.0025
120 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
121 OCULAR HYPERAEMIA 119 0.0025
122 NIGHT BLINDNESS 4 0.0025
123 CHOROIDAL EFFUSION 2 0.0025
124 MONOCYTE COUNT INCREASED 9 0.0025
125 EYELID SKIN DRYNESS 3 0.0025
126 ENTEROCOCCAL SEPSIS 2 0.0025
127 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
128 BLOOD CHLORIDE INCREASED 4 0.0023
129 HERPES OPHTHALMIC 3 0.0023
130 RHINITIS ALLERGIC 10 0.0022
131 DRY EYE 111 0.0022
132 INFUSION SITE RASH 3 0.0022
133 ESSENTIAL HYPERTENSION 4 0.0022
134 MEAN CELL HAEMOGLOBIN DECREASED 4 0.0022
135 VITRITIS 4 0.0022
136 INFUSION SITE INFECTION 5 0.0021
137 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 3 0.0021
138 LYMPHOCYTE COUNT INCREASED 7 0.0021
139 AUDITORY DISORDER 3 0.0021
140 OCULAR HYPERTENSION 4 0.0021
141 NORMOCYTIC ANAEMIA 3 0.0020
142 AUTONOMIC NEUROPATHY 2 0.0020
143 EYE SWELLING 73 0.0020
144 CONJUNCTIVAL OEDEMA 2 0.0019
145 CAROTID ARTERIOSCLEROSIS 2 0.0019
146 PRODUCT DEPOSIT 3 0.0019
147 EYELIDS PRURITUS 6 0.0019
148 ONYCHOLYSIS 3 0.0019
149 PROTEIN TOTAL INCREASED 5 0.0019
150 METABOLIC ALKALOSIS 3 0.0019
151 PARANASAL SINUS DISCOMFORT 7 0.0018
152 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
153 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
154 HAEMATOCRIT INCREASED 4 0.0018
155 VITREOUS FLOATERS 17 0.0017
156 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
157 DEVICE ALARM ISSUE 3 0.0017
158 INTRAOCULAR PRESSURE INCREASED 21 0.0016
159 BLOOD UREA DECREASED 2 0.0016
160 IMPAIRED QUALITY OF LIFE 23 0.0016
161 PERIORBITAL SWELLING 9 0.0016
162 RETINAL OEDEMA 3 0.0016
163 GINGIVAL RECESSION 3 0.0016
164 MEAN CELL VOLUME INCREASED 4 0.0016
165 DACRYOSTENOSIS ACQUIRED 2 0.0015
166 EYE PRURITUS 52 0.0015
167 RADICULOPATHY 4 0.0015
168 ACROCHORDON 2 0.0015
169 ANION GAP INCREASED 2 0.0015
170 BODY MASS INDEX INCREASED 2 0.0015
171 CALCULUS BLADDER 2 0.0015
172 SUBDURAL HAEMORRHAGE 4 0.0015
173 RHINALGIA 4 0.0015
174 NEUROGENIC BLADDER 3 0.0014
175 BRONCHIOLITIS 5 0.0014
176 ALVEOLITIS 2 0.0014
177 CEREBELLAR HAEMORRHAGE 2 0.0014
178 HORDEOLUM 6 0.0014
179 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2 0.0014
180 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
181 AXILLARY PAIN 2 0.0013
182 ENDOPHTHALMITIS 8 0.0013
183 AGE-RELATED MACULAR DEGENERATION 2 0.0013
184 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
185 EYELID OEDEMA 15 0.0013
186 PRE-EXISTING CONDITION IMPROVED 8 0.0013
187 EAR DISCOMFORT 13 0.0013
188 EOSINOPHIL COUNT DECREASED 3 0.0013
189 MACULAR OEDEMA 7 0.0012
190 EYE INFECTION 14 0.0012
191 EYE OEDEMA 3 0.0012
192 COLONIC POLYP 2 0.0012
193 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
194 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
195 ANGLE CLOSURE GLAUCOMA 3 0.0012
196 VITAMIN D DECREASED 10 0.0012
197 ACUTE SINUSITIS 2 0.0012
198 FAILURE TO THRIVE 6 0.0012
199 CAROTID ARTERY STENOSIS 4 0.0011
200 VISUAL ACUITY REDUCED 38 0.0011
201 PHOTOPSIA 7 0.0011
202 EAR CONGESTION 3 0.0011
203 VISION BLURRED 152 0.0011
204 ABDOMINAL RIGIDITY 3 0.0011
205 MAJOR DEPRESSION 8 0.0011
206 PRODUCT ADMINISTRATION ERROR 22 0.0011
207 VITREOUS HAEMORRHAGE 3 0.0011
208 NEUTROPHIL COUNT INCREASED 11 0.0011
209 PRODUCT CONTAINER ISSUE 9 0.0010
210 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
211 NAIL DISORDER 9 0.0010
212 SPINAL OSTEOARTHRITIS 9 0.0010
213 BLOOD UREA INCREASED 17 0.0010
214 HOSPICE CARE 10 0.0010
215 TINNITUS 45 0.0010
216 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
217 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
218 EAR PAIN 19 0.0010
219 BLOOD CREATININE DECREASED 3 0.0010
220 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
221 IRIDOCYCLITIS 3 0.0009
222 PURULENT DISCHARGE 4 0.0009
223 OVERWEIGHT 5 0.0009
224 URINE OUTPUT DECREASED 8 0.0009
225 CLOSTRIDIUM TEST POSITIVE 2 0.0009
226 PEPTIC ULCER 3 0.0009
227 BACTERIAL TEST POSITIVE 2 0.0009
228 FACIAL PAIN 8 0.0009
229 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
230 EYELID PTOSIS 9 0.0009
231 DIABETIC RETINOPATHY 3 0.0009
232 BRAIN OPERATION 2 0.0009
233 EYE OPERATION 4 0.0009
234 SEASONAL ALLERGY 12 0.0008
235 HAEMORRHAGIC DIATHESIS 3 0.0008
236 HYPERVOLAEMIA 4 0.0008
237 PROTEIN TOTAL DECREASED 3 0.0008
238 BLEPHAROSPASM 5 0.0008
239 SNORING 3 0.0008
240 DYSLIPIDAEMIA 4 0.0008
241 AORTIC ARTERIOSCLEROSIS 2 0.0008
242 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
243 TRISMUS 4 0.0008
244 FAECES HARD 3 0.0008
245 RHINOVIRUS INFECTION 3 0.0008
246 ACTINIC KERATOSIS 2 0.0008
247 DISCOMFORT 47 0.0008
248 MULTIPLE ALLERGIES 6 0.0008
249 PNEUMONIA FUNGAL 3 0.0008
250 TRICUSPID VALVE INCOMPETENCE 6 0.0008
251 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
252 HYPERLIPIDAEMIA 9 0.0008
253 CEREBRAL ATROPHY 3 0.0008
254 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
255 FOREIGN BODY 3 0.0007
256 FUNGAL SKIN INFECTION 3 0.0007
257 VITAMIN B12 DEFICIENCY 3 0.0007
258 BLOOD PHOSPHORUS INCREASED 2 0.0007
259 HYPERURICAEMIA 3 0.0007
260 ECCHYMOSIS 5 0.0007
261 ONYCHOCLASIS 5 0.0007
262 GASTRIC ULCER HAEMORRHAGE 4 0.0007
263 HAEMORRHOIDS 14 0.0007
264 MALNUTRITION 8 0.0007
265 ENDOTRACHEAL INTUBATION 2 0.0007
266 INFUSION SITE ERYTHEMA 6 0.0007
267 MITRAL VALVE INCOMPETENCE 8 0.0007
268 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
269 CATARACT 42 0.0007
270 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
271 EYE DISORDER 23 0.0007
272 BLOOD MAGNESIUM DECREASED 6 0.0007
273 DIVERTICULUM INTESTINAL 3 0.0007
274 DEVICE USE ISSUE 12 0.0007
275 BLOOD CALCIUM INCREASED 6 0.0007
276 GINGIVAL SWELLING 3 0.0007
277 CREPITATIONS 2 0.0007
278 IRON DEFICIENCY 3 0.0007
279 TROPONIN INCREASED 5 0.0007
280 HAEMATOCRIT DECREASED 13 0.0007
281 DUODENITIS 2 0.0007
282 RENAL FAILURE CHRONIC 5 0.0006
283 LOCALISED OEDEMA 3 0.0006
284 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
285 PELVIC FRACTURE 5 0.0006
286 OESOPHAGITIS 7 0.0006
287 NASAL DRYNESS 4 0.0006
288 INFUSION SITE SWELLING 4 0.0006
289 SKIN ABRASION 3 0.0006
290 NASAL DISCOMFORT 5 0.0006
291 SLEEP APNOEA SYNDROME 12 0.0006
292 HYPOXIA 22 0.0006
293 ACUTE RESPIRATORY FAILURE 12 0.0006
294 CUSHINGOID 2 0.0006
295 GLAUCOMA 12 0.0006
296 DIPLOPIA 16 0.0006
297 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
298 VITAMIN D DEFICIENCY 6 0.0006
299 DECUBITUS ULCER 5 0.0006
300 BREAST ENLARGEMENT 2 0.0006
301 LEUKOCYTOSIS 11 0.0006
302 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
303 MADAROSIS 7 0.0006
304 HYPERNATRAEMIA 3 0.0006
305 EOSINOPHIL COUNT INCREASED 5 0.0006
306 ECONOMIC PROBLEM 9 0.0006
307 POSTOPERATIVE WOUND INFECTION 4 0.0006
308 CLOSTRIDIAL INFECTION 2 0.0006
309 B-CELL LYMPHOMA 2 0.0006
310 PETIT MAL EPILEPSY 3 0.0006
311 FEMORAL NECK FRACTURE 3 0.0006
312 ENDOCARDITIS 3 0.0006
313 EYE MOVEMENT DISORDER 4 0.0006
314 BRONCHOPNEUMONIA 2 0.0006
315 PERIPHERAL VASCULAR DISORDER 3 0.0006
316 VARICOSE VEIN 3 0.0006
317 HYPERBILIRUBINAEMIA 6 0.0006
318 ERYTHEMA NODOSUM 2 0.0006
319 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
320 SMALL INTESTINAL OBSTRUCTION 7 0.0006
321 IMMUNOSUPPRESSION 5 0.0006
322 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
323 GRAFT VERSUS HOST DISEASE 4 0.0006
324 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
325 VISUAL IMPAIRMENT 68 0.0005
326 RETINAL DETACHMENT 5 0.0005
327 INCREASED TENDENCY TO BRUISE 5 0.0005
328 SKIN ULCER 14 0.0005
329 HIATUS HERNIA 7 0.0005
330 MENTAL STATUS CHANGES 15 0.0005
331 CONJUNCTIVITIS 10 0.0005
332 HEPATIC STEATOSIS 10 0.0005
333 ANGIOPATHY 3 0.0005
334 DEFORMITY 5 0.0005
335 SKIN INFECTION 6 0.0005
336 PRODUCT LEAKAGE 3 0.0005
337 INCORRECT PRODUCT STORAGE 7 0.0005
338 AORTIC ANEURYSM 4 0.0005
339 HAEMODYNAMIC INSTABILITY 4 0.0005
340 EYE HAEMORRHAGE 7 0.0005
341 ACIDOSIS 4 0.0005
342 COMMUNICATION DISORDER 2 0.0005
343 LIPASE INCREASED 4 0.0005
344 EXERCISE TOLERANCE DECREASED 3 0.0005
345 ATELECTASIS 5 0.0005
346 UVEITIS 7 0.0005
347 APHTHOUS ULCER 4 0.0005
348 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
349 THERAPY PARTIAL RESPONDER 8 0.0005
350 EMOTIONAL DISTRESS 62 0.0005
351 DECREASED INTEREST 3 0.0005
352 DISABILITY 10 0.0005
353 BACTERAEMIA 6 0.0005
354 CATARACT OPERATION 3 0.0005
355 SINUS HEADACHE 3 0.0005
356 RENAL CYST 4 0.0005
357 HYPOMAGNESAEMIA 7 0.0005
358 CANDIDIASIS 2 0.0005
359 RHINITIS 4 0.0005
360 ENURESIS 2 0.0005
361 PHARYNGITIS 6 0.0005
362 INFUSION SITE EXTRAVASATION 3 0.0005
363 COAGULOPATHY 8 0.0005
364 CONGESTIVE CARDIOMYOPATHY 2 0.0005
365 TYPE 2 DIABETES MELLITUS 16 0.0005
366 SENSATION OF FOREIGN BODY 4 0.0005
367 PROTEINURIA 9 0.0005
368 AORTIC VALVE INCOMPETENCE 2 0.0005
369 ABSCESS LIMB 2 0.0005
370 BODY HEIGHT DECREASED 5 0.0005
371 ALCOHOLISM 2 0.0005
372 PROCTALGIA 3 0.0005
373 PSEUDOMONAS INFECTION 4 0.0005
374 INFUSION SITE PAIN 6 0.0005
375 RHINORRHOEA 30 0.0005
376 MULTI-ORGAN FAILURE 8 0.0005
377 CHAPPED LIPS 2 0.0005
378 PLATELET COUNT INCREASED 6 0.0005
379 WALKING AID USER 3 0.0005
380 RED BLOOD CELL COUNT DECREASED 13 0.0005
381 SINUS DISORDER 9 0.0005
382 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
383 LYMPHOCYTE COUNT DECREASED 8 0.0005
384 CARDIAC FAILURE ACUTE 3 0.0004
385 POST-TRAUMATIC STRESS DISORDER 3 0.0004
386 QUALITY OF LIFE DECREASED 6 0.0004
387 SNEEZING 10 0.0004
388 SINUS CONGESTION 6 0.0004
389 TASTE DISORDER 9 0.0004
390 BLINDNESS 18 0.0004
391 RESPIRATORY TRACT CONGESTION 7 0.0004
392 DERMATITIS CONTACT 5 0.0004
393 SCAB 5 0.0004
394 EAR DISORDER 2 0.0004
395 RESPIRATION ABNORMAL 3 0.0004
396 JOINT EFFUSION 3 0.0004
397 GASTRIC HAEMORRHAGE 5 0.0004
398 LYMPHOEDEMA 3 0.0004
399 THERAPY INTERRUPTED 31 0.0004
400 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
401 IRON DEFICIENCY ANAEMIA 4 0.0004
402 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
403 MUSCLE TIGHTNESS 7 0.0004
404 HYPERTRANSAMINASAEMIA 3 0.0004
405 CARPAL TUNNEL SYNDROME 6 0.0004
406 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
407 SPUTUM DISCOLOURED 4 0.0004
408 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
409 CELLULITIS 21 0.0004
410 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
411 VISUAL FIELD DEFECT 3 0.0004
412 ENTEROCOCCAL INFECTION 2 0.0004
413 FAECES SOFT 3 0.0004
414 DIZZINESS POSTURAL 4 0.0004
415 FLUID OVERLOAD 6 0.0004
416 HYPOKALAEMIA 19 0.0004
417 NECK PAIN 23 0.0004
418 ACCIDENTAL OVERDOSE 15 0.0004
419 NASAL CONGESTION 24 0.0004
420 CYTOPENIA 5 0.0004
421 HEPATOMEGALY 4 0.0004
422 BLINDNESS TRANSIENT 3 0.0004
423 HYPOPHOSPHATAEMIA 3 0.0004
424 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
425 BREATH SOUNDS ABNORMAL 2 0.0004
426 BRONCHITIS 30 0.0004
427 FEELING DRUNK 3 0.0004
428 CYST 5 0.0004
429 ABDOMINAL TENDERNESS 2 0.0004
430 ILEUS 5 0.0004
431 HYDRONEPHROSIS 3 0.0004
432 DERMATITIS EXFOLIATIVE 2 0.0004
433 BLOOD POTASSIUM DECREASED 12 0.0004
434 EMPHYSEMA 4 0.0004
435 BOWEL MOVEMENT IRREGULARITY 3 0.0004
436 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
437 SEPTIC SHOCK 17 0.0004
438 SINUSITIS 40 0.0004
439 ROTATOR CUFF SYNDROME 5 0.0004
440 PERICARDIAL EFFUSION 9 0.0004
441 RESPIRATORY FAILURE 28 0.0004
442 TENDERNESS 4 0.0004
443 PETECHIAE 4 0.0004
444 BLOOD CREATININE INCREASED 25 0.0004
445 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
446 GASTRITIS 10 0.0004
447 BLOOD ALBUMIN DECREASED 3 0.0004
448 OSTEOARTHRITIS 16 0.0004
449 GINGIVAL PAIN 3 0.0004
450 OBESITY 6 0.0004
451 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
452 SCIATICA 6 0.0004
453 ANAL FISTULA 2 0.0004
454 HIP FRACTURE 12 0.0004
455 BRUXISM 2 0.0004
456 NEURALGIA 9 0.0004
457 SKIN LACERATION 4 0.0004
458 TACHYPNOEA 5 0.0004
459 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
460 ASPIRATION 4 0.0004
461 LOWER LIMB FRACTURE 7 0.0004
462 PHOTOSENSITIVITY REACTION 6 0.0004
463 CHOKING SENSATION 2 0.0004
464 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
465 FEBRILE NEUTROPENIA 24 0.0004
466 DENTAL CARIES 4 0.0004
467 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
468 EMBOLISM 3 0.0004
469 PNEUMONIA ASPIRATION 9 0.0004
470 NEPHROPATHY TOXIC 4 0.0004
471 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
472 BLINDNESS UNILATERAL 5 0.0004
473 HYPOPHAGIA 9 0.0004
474 IMPAIRED DRIVING ABILITY 4 0.0004
475 PYELONEPHRITIS 3 0.0003
476 DYSPNOEA EXERTIONAL 13 0.0003
477 ELECTROLYTE IMBALANCE 4 0.0003
478 VASCULITIS 4 0.0003
479 TUMOUR LYSIS SYNDROME 3 0.0003
480 LUNG INFILTRATION 3 0.0003
481 ENERGY INCREASED 2 0.0003
482 RESPIRATORY RATE INCREASED 3 0.0003
483 DYSPHAGIA 32 0.0003
484 PULMONARY HYPERTENSION 7 0.0003
485 PULMONARY MASS 5 0.0003
486 MACULAR DEGENERATION 4 0.0003
487 MYOSITIS 3 0.0003
488 URINARY TRACT INFECTION 57 0.0003
489 DRY MOUTH 27 0.0003
490 MUSCLE SPASMS 61 0.0003
491 OROPHARYNGEAL DISCOMFORT 3 0.0003
492 SEPSIS 37 0.0003
493 HALLUCINATION, VISUAL 7 0.0003
494 OSTEOMYELITIS 6 0.0003
495 LOCALISED INFECTION 8 0.0003
496 DEHYDRATION 44 0.0003
497 BURSITIS 4 0.0003
498 ADRENAL INSUFFICIENCY 4 0.0003
499 ATRIAL FIBRILLATION 32 0.0003
500 EXOSTOSIS 3 0.0003
501 SKIN LESION 9 0.0003
502 ANXIETY 93 0.0003
503 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
504 CARDIOMEGALY 4 0.0003
505 UROSEPSIS 3 0.0003
506 PRODUCT DISTRIBUTION ISSUE 3 0.0003
507 CONTUSION 31 0.0003
508 DIARRHOEA HAEMORRHAGIC 3 0.0003
509 ACUTE MYELOID LEUKAEMIA 5 0.0003
510 OXYGEN SATURATION DECREASED 18 0.0003
511 FLANK PAIN 3 0.0003
512 SECRETION DISCHARGE 4 0.0003
513 LACERATION 3 0.0003
514 LEUKAEMIA 3 0.0003
515 SPINAL DISORDER 3 0.0003
516 COLITIS 12 0.0003
517 HEAD INJURY 10 0.0003
518 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
519 ACUTE KIDNEY INJURY 48 0.0003
520 HYPOTHYROIDISM 10 0.0003
521 POST PROCEDURAL COMPLICATION 6 0.0003
522 VERTIGO 19 0.0003
523 DEEP VEIN THROMBOSIS 20 0.0003
524 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
525 RENAL FAILURE ACUTE 13 0.0003
526 THERAPY CHANGE 3 0.0003
527 ASPERGILLUS INFECTION 2 0.0003
528 MUSCLE TWITCHING 7 0.0003
529 TOOTH INFECTION 4 0.0003
530 PULMONARY CONGESTION 4 0.0003
531 OROPHARYNGEAL PAIN 28 0.0003
532 DYSURIA 11 0.0003
533 BREAST MASS 2 0.0003
534 COLITIS ISCHAEMIC 2 0.0003
535 CANDIDA INFECTION 5 0.0003
536 DISEASE PROGRESSION 35 0.0003
537 SLUGGISHNESS 3 0.0003
538 DRUG TOXICITY 4 0.0003
539 IMPAIRED GASTRIC EMPTYING 4 0.0003
540 BLOOD TESTOSTERONE DECREASED 2 0.0003
541 HELICOBACTER INFECTION 3 0.0003
542 TEMPERATURE INTOLERANCE 3 0.0003
543 CARDIAC ARREST 24 0.0003
544 RESPIRATORY DISTRESS 8 0.0003
545 ENCEPHALITIS 2 0.0003
546 PRODUCT DOSE OMISSION ISSUE 85 0.0003
547 VENTRICULAR EXTRASYSTOLES 3 0.0003
548 DIVERTICULITIS 8 0.0003
549 ORAL DISCOMFORT 4 0.0003
550 CARDIAC FAILURE CONGESTIVE 23 0.0003
551 HEART RATE DECREASED 10 0.0003
552 BRADYCARDIA 15 0.0003
553 LYMPHADENOPATHY 10 0.0003
554 FALL 94 0.0003
555 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
556 SINUS TACHYCARDIA 4 0.0003
557 DIVERTICULUM 2 0.0003
558 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
559 EPISTAXIS 21 0.0003
560 SYNCOPE 28 0.0003
561 BLOOD CHOLESTEROL INCREASED 13 0.0003
562 GOUT 5 0.0003
563 BALANCE DISORDER 24 0.0003
564 PHARYNGITIS STREPTOCOCCAL 3 0.0003
565 GASTROENTERITIS VIRAL 5 0.0003
566 ANOSMIA 4 0.0003
567 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
568 CONSTIPATION 60 0.0003
569 RESTLESS LEGS SYNDROME 5 0.0003
570 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
571 STAPHYLOCOCCAL INFECTION 9 0.0003
572 GASTROINTESTINAL PAIN 3 0.0003
573 ASCITES 8 0.0003
574 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 55 0.0003
575 ACUTE MYOCARDIAL INFARCTION 8 0.0003
576 CEREBRAL DISORDER 2 0.0003
577 ARTHROPOD BITE 2 0.0003
578 SKIN DISORDER 9 0.0003
579 PANCYTOPENIA 15 0.0003
580 THROMBOCYTOPENIA 30 0.0003
581 ARTHRITIS 21 0.0003
582 HYPOAESTHESIA ORAL 4 0.0003
583 BLOOD SODIUM DECREASED 5 0.0003
584 CORONARY ARTERY DISEASE 8 0.0003
585 HYPOCALCAEMIA 5 0.0003
586 POLLAKIURIA 11 0.0003
587 OSTEOPENIA 4 0.0003
588 GASTRIC ULCER 5 0.0003
589 HAEMATURIA 9 0.0003
590 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
591 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
592 DEVICE RELATED INFECTION 4 0.0003
593 ATRIOVENTRICULAR BLOCK 2 0.0003
594 TENDONITIS 4 0.0003
595 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
596 HYPERKALAEMIA 9 0.0003
597 HYPOACUSIS 11 0.0003
598 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
599 BLOOD GLUCOSE INCREASED 48 0.0003
600 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
601 COVID-19 PNEUMONIA 3 0.0003
602 HAEMOGLOBIN DECREASED 26 0.0003
603 ASTHENIA 95 0.0003
604 PRODUCTIVE COUGH 12 0.0003
605 ATRIAL FLUTTER 2 0.0003
606 CHRONIC KIDNEY DISEASE 19 0.0002
607 BLISTER 14 0.0002
608 SENSORY DISTURBANCE 4 0.0002
609 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
610 HEADACHE 156 0.0002
611 HYPONATRAEMIA 14 0.0002
612 NOCTURIA 3 0.0002
613 LACTIC ACIDOSIS 8 0.0002
614 FIBROMYALGIA 6 0.0002
615 BLOOD POTASSIUM INCREASED 4 0.0002
616 OEDEMA PERIPHERAL 30 0.0002
617 COUGH 69 0.0002
618 HYPOTENSION 49 0.0002
619 MUSCLE SPASTICITY 3 0.0002
620 IMPAIRED HEALING 8 0.0002
621 RIB FRACTURE 5 0.0002
622 HYPERCALCAEMIA 3 0.0002
623 LOSS OF CONSCIOUSNESS 31 0.0002
624 NEUROPATHY PERIPHERAL 23 0.0002
625 VIRAL INFECTION 8 0.0002
626 WEIGHT DECREASED 67 0.0002
627 URINARY RETENTION 8 0.0002
628 ATRIAL SEPTAL DEFECT 2 0.0002
629 DERMATITIS 5 0.0002
630 IMPAIRED WORK ABILITY 5 0.0002
631 LIVER FUNCTION TEST INCREASED 5 0.0002
632 MUSCULOSKELETAL DISCOMFORT 4 0.0002
633 PARANOIA 4 0.0002
634 PLEURAL EFFUSION 14 0.0002
635 ORTHOSTATIC HYPOTENSION 4 0.0002
636 MUCOSAL INFLAMMATION 6 0.0002
637 CONFUSIONAL STATE 37 0.0002
638 NEUROTOXICITY 4 0.0002
639 NASOPHARYNGITIS 42 0.0002
640 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
641 LETHARGY 13 0.0002
642 HEAD DISCOMFORT 4 0.0002
643 CHEST DISCOMFORT 23 0.0002
644 DIZZINESS 112 0.0002
645 THIRST 4 0.0002
646 RASH PAPULAR 5 0.0002
647 FEAR 6 0.0002
648 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
649 THROAT IRRITATION 10 0.0002
650 DYSKINESIA 9 0.0002
651 CHEST PAIN 41 0.0002
652 TOOTHACHE 4 0.0002
653 PERIPHERAL SWELLING 34 0.0002
654 ANAEMIA 42 0.0002
655 MUSCULAR WEAKNESS 25 0.0002
656 CYSTITIS 7 0.0002
657 TREATMENT NONCOMPLIANCE 12 0.0002
658 END STAGE RENAL DISEASE 4 0.0002
659 PERIPHERAL COLDNESS 3 0.0002
660 SHOCK 5 0.0002
661 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
662 BACK PAIN 50 0.0002
663 INFLUENZA 24 0.0002
664 ROAD TRAFFIC ACCIDENT 9 0.0002
665 HAEMOPTYSIS 6 0.0002
666 SWELLING FACE 14 0.0002
667 APHONIA 3 0.0002
668 HOSPITALISATION 33 0.0002
669 WOUND 6 0.0002
670 MASS 3 0.0002
671 ERYTHEMA MULTIFORME 2 0.0002
672 STOMATITIS 13 0.0002
673 COGNITIVE DISORDER 10 0.0002
674 CHOLELITHIASIS 7 0.0002
675 INJURY 15 0.0002
676 HEPATIC CIRRHOSIS 4 0.0002
677 ARTERIOSCLEROSIS 2 0.0002
678 GASTROINTESTINAL DISORDER 19 0.0002
679 PAIN IN JAW 6 0.0002
680 BLOOD URINE PRESENT 4 0.0002
681 SPEECH DISORDER 11 0.0002
682 DRY SKIN 28 0.0002
683 INCREASED APPETITE 4 0.0002
684 HYPERSOMNIA 6 0.0002
685 MULTIPLE SCLEROSIS 10 0.0002
686 PARAESTHESIA ORAL 3 0.0002
687 INJECTION SITE HAEMATOMA 3 0.0002
688 PAIN 127 0.0002
689 CHILLS 24 0.0002
690 LUNG DISORDER 10 0.0002
691 DYSPNOEA 115 0.0002
692 FATIGUE 158 0.0002
693 TACHYCARDIA 18 0.0002
694 DISORIENTATION 8 0.0002
695 PULMONARY OEDEMA 9 0.0002
696 THERAPY NON-RESPONDER 9 0.0002
697 CYTOKINE RELEASE SYNDROME 4 0.0002
698 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
699 FULL BLOOD COUNT DECREASED 4 0.0002
700 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
701 DRY THROAT 2 0.0002
702 INSURANCE ISSUE 3 0.0002
703 INSOMNIA 52 0.0002
704 THERAPY CESSATION 10 0.0002
705 PNEUMONIA 63 0.0002
706 ANKLE FRACTURE 3 0.0002
707 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
708 PERITONITIS 4 0.0002
709 RASH GENERALISED 5 0.0002
710 RESPIRATORY TRACT INFECTION 5 0.0002
711 MEMORY IMPAIRMENT 26 0.0002
712 DISEASE RECURRENCE 9 0.0002
713 PNEUMOTHORAX 3 0.0002
714 HYPERTENSION 40 0.0002
715 DYSPHONIA 11 0.0002
716 EATING DISORDER 4 0.0002
717 JOINT INJURY 4 0.0002
718 RECTAL HAEMORRHAGE 8 0.0002
719 BLOOD BILIRUBIN INCREASED 5 0.0002
720 ABDOMINAL DISCOMFORT 31 0.0002
721 BACK DISORDER 3 0.0002
722 FAECES DISCOLOURED 4 0.0002
723 OEDEMA 10 0.0002
724 SLEEP DISORDER 13 0.0002
725 BIPOLAR DISORDER 2 0.0002
726 PRODUCT DOSE OMISSION 12 0.0002
727 BLOOD PRESSURE INCREASED 28 0.0002
728 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 33 0.0002
729 MELAENA 4 0.0002
730 ANGIOEDEMA 8 0.0002
731 DECREASED APPETITE 42 0.0002
732 RENAL FAILURE 24 0.0002
733 ARTHROPATHY 10 0.0002
734 RASH MACULO-PAPULAR 4 0.0002
735 FEELING COLD 5 0.0002
736 DEMENTIA 5 0.0002
737 ORAL PAIN 4 0.0002
738 PERICARDITIS 3 0.0002
739 HYPERHIDROSIS 23 0.0002
740 BLOOD CALCIUM DECREASED 2 0.0002
741 SKIN EXFOLIATION 15 0.0002
742 FLUID RETENTION 9 0.0002
743 PRODUCT AVAILABILITY ISSUE 4 0.0002
744 DIARRHOEA 113 0.0002
745 INFLAMMATION 9 0.0002
746 SKIN DISCOLOURATION 8 0.0002
747 HYPOAESTHESIA 26 0.0002
748 NIGHTMARE 6 0.0002
749 HOT FLUSH 13 0.0002
750 HEART RATE INCREASED 17 0.0002
751 INTENTIONAL PRODUCT MISUSE 15 0.0002
752 MYALGIA 29 0.0002
753 COLD SWEAT 3 0.0002
754 OSTEOPOROSIS 7 0.0002
755 DRUG DOSE OMISSION 28 0.0002
756 WHEEZING 10 0.0002
757 BLOOD IRON DECREASED 2 0.0002
758 MIGRAINE 16 0.0002
759 GAIT DISTURBANCE 32 0.0002
760 RESPIRATORY DISORDER 5 0.0002
761 HYPERSENSITIVITY 31 0.0002
762 DISTURBANCE IN ATTENTION 9 0.0002
763 BLOOD PRESSURE FLUCTUATION 4 0.0002
764 BLOOD GLUCOSE DECREASED 8 0.0002
765 CEREBROVASCULAR ACCIDENT 28 0.0002
766 PELVIC PAIN 3 0.0002
767 BONE DISORDER 3 0.0002
768 CEREBRAL INFARCTION 4 0.0002
769 PRODUCT QUALITY ISSUE 22 0.0002
770 CARDIAC FAILURE 13 0.0002
771 PYREXIA 56 0.0002
772 FEMUR FRACTURE 5 0.0002
773 AGEUSIA 4 0.0002
774 PLATELET COUNT DECREASED 17 0.0002
775 ABDOMINAL PAIN 37 0.0002
776 DERMATITIS ALLERGIC 2 0.0002
777 INFECTION 23 0.0002
778 UNEVALUABLE EVENT 12 0.0002
779 RHEUMATOID ARTHRITIS 18 0.0002
780 FRACTURE 3 0.0002
781 FOOT FRACTURE 3 0.0002
782 HAEMATEMESIS 4 0.0002
783 JOINT SWELLING 19 0.0002
784 BURNING SENSATION 11 0.0002
785 TREMOR 26 0.0002
786 NAUSEA 123 0.0002
787 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
788 UNRESPONSIVE TO STIMULI 4 0.0002
789 CHOKING 3 0.0002
790 RASH 67 0.0002
791 NERVOUSNESS 8 0.0002
792 SEDATION 4 0.0002
793 NEPHROLITHIASIS 7 0.0002
794 JOINT STIFFNESS 4 0.0002
795 BEDRIDDEN 2 0.0002
796 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
797 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
798 ABNORMAL BEHAVIOUR 6 0.0002
799 DEPRESSED MOOD 8 0.0002
800 ERYTHEMA 31 0.0002
801 UNDERDOSE 11 0.0002
802 UPPER LIMB FRACTURE 3 0.0002
803 BLOOD PRESSURE DECREASED 10 0.0002
804 EAR INFECTION 4 0.0002
805 FUNGAL INFECTION 5 0.0001
806 AGITATION 11 0.0001
807 SPINAL FRACTURE 3 0.0001
808 THROMBOSIS 12 0.0001
809 PAIN OF SKIN 4 0.0001
810 COVID-19 26 0.0001
811 NEUTROPHIL COUNT DECREASED 6 0.0001
812 PALLOR 4 0.0001
813 FEELING HOT 9 0.0001
814 RASH ERYTHEMATOUS 7 0.0001
815 PARAESTHESIA 23 0.0001
816 CORONARY ARTERY OCCLUSION 2 0.0001
817 ABDOMINAL PAIN UPPER 30 0.0001
818 HAEMATOCHEZIA 8 0.0001
819 CONDITION AGGRAVATED 44 0.0001
820 TOOTH LOSS 3 0.0001
821 DIABETES MELLITUS 11 0.0001
822 RHABDOMYOLYSIS 6 0.0001
823 PRODUCT USE ISSUE 27 0.0001
824 HAEMORRHAGE 15 0.0001
825 COORDINATION ABNORMAL 2 0.0001
826 RASH MACULAR 5 0.0001
827 DYSPEPSIA 14 0.0001
828 DEVICE OCCLUSION 2 0.0001
829 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
830 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
831 FLATULENCE 8 0.0001
832 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
833 RETCHING 3 0.0001
834 DEPRESSION 32 0.0001
835 BRONCHOSPASM 2 0.0001
836 ARTHRALGIA 58 0.0001
837 CARDIAC DISORDER 13 0.0001
838 SWELLING 13 0.0001
839 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
840 ALOPECIA 27 0.0001
841 HYPERGLYCAEMIA 5 0.0001
842 PRODUCT STORAGE ERROR 12 0.0001
843 DYSSTASIA 4 0.0001
844 MUSCULOSKELETAL STIFFNESS 12 0.0001
845 PALPITATIONS 16 0.0001
846 PAIN IN EXTREMITY 40 0.0001
847 URINARY INCONTINENCE 4 0.0001
848 STEVENS-JOHNSON SYNDROME 3 0.0001
849 TOOTH DISORDER 3 0.0001
850 SOMNOLENCE 27 0.0001
851 GLOSSODYNIA 3 0.0001
852 INFLUENZA LIKE ILLNESS 11 0.0001
853 IRRITABILITY 8 0.0001
854 HEPATIC FAILURE 4 0.0001
855 INTESTINAL OBSTRUCTION 5 0.0001
856 APHASIA 4 0.0001
857 MALAISE 58 0.0001
858 VOMITING 62 0.0001
859 DRUG DISPENSING ERROR 2 0.0001
860 WEIGHT INCREASED 29 0.0001
861 BASAL CELL CARCINOMA 2 0.0001
862 SWOLLEN TONGUE 4 0.0001
863 BRAIN FOG 2 0.0001
864 PRURITUS 49 0.0001
865 CYANOSIS 2 0.0001
866 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
867 MOBILITY DECREASED 9 0.0001
868 NEUTROPENIA 17 0.0001
869 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
870 MOVEMENT DISORDER 4 0.0001
871 INTERSTITIAL LUNG DISEASE 6 0.0001
872 AMNESIA 8 0.0001
873 ENCEPHALOPATHY 3 0.0001
874 HERPES ZOSTER 7 0.0001
875 ABASIA 3 0.0001
876 SEIZURE 14 0.0001
877 DRUG LEVEL INCREASED 2 0.0001
878 INFUSION RELATED REACTION 8 0.0001
879 EXPIRED PRODUCT ADMINISTERED 4 0.0001
880 CYTOMEGALOVIRUS INFECTION 2 0.0001
881 LIP SWELLING 4 0.0001
882 LEUKOPENIA 6 0.0001
883 CARDIO-RESPIRATORY ARREST 5 0.0001
884 BONE PAIN 7 0.0001
885 SURGERY 7 0.0001
886 PRODUCT COMPLAINT 3 0.0001
887 CARDIOVASCULAR DISORDER 3 0.0001
888 HEPATITIS 3 0.0001
889 ERECTILE DYSFUNCTION 3 0.0001
890 GASTRIC DISORDER 4 0.0001
891 HAEMATOMA 3 0.0001
892 EXPOSURE VIA SKIN CONTACT 3 0.0001
893 DEVICE DEFECTIVE 2 0.0001
894 MENTAL DISORDER 5 0.0001
895 ECZEMA 6 0.0001
896 ANHEDONIA 3 0.0001
897 DRUG ERUPTION 2 0.0001
898 FEELING ABNORMAL 27 0.0001
899 RASH PRURITIC 6 0.0001
900 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
901 SUICIDAL IDEATION 10 0.0001
902 SKIN IRRITATION 5 0.0001
903 TREATMENT FAILURE 9 0.0001
904 BLOOD GLUCOSE ABNORMAL 2 0.0001
905 DRUG INEFFECTIVE 142 0.0001
906 URTICARIA 18 0.0001
907 OFF LABEL USE 94 0.0001
908 BACTERIAL INFECTION 2 0.0001
909 RENAL IMPAIRMENT 9 0.0001
910 ASTHMA 12 0.0001
911 HALLUCINATION 8 0.0001
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
913 CHOLESTASIS 2 0.0001
914 DEATH 89 0.0001
915 HYPOGLYCAEMIA 5 0.0001
916 NEEDLE ISSUE 3 0.0001
917 LABORATORY TEST ABNORMAL 3 0.0001
918 RENAL INJURY 3 0.0001
919 COMPLICATION OF DEVICE INSERTION 2 0.0001
920 BONE MARROW FAILURE 2 0.0001
921 FLUSHING 10 0.0001
922 BODY TEMPERATURE INCREASED 2 0.0001
923 DRUG ADMINISTRATION ERROR 3 0.0001
924 LIMB DISCOMFORT 3 0.0001
925 ABDOMINAL DISTENSION 10 0.0001
926 MUSCULOSKELETAL PAIN 5 0.0001
927 PANCREATITIS 5 0.0001
928 DYSGEUSIA 7 0.0001
929 METABOLIC ACIDOSIS 3 0.0001
930 NIGHT SWEATS 3 0.0001
931 INCORRECT DOSE ADMINISTERED 21 0.0001
932 OSTEONECROSIS 3 0.0001
933 APPLICATION SITE PAIN 2 0.0001
934 ANAPHYLACTIC REACTION 5 0.0001
935 NEOPLASM MALIGNANT 6 0.0001
936 GAIT INABILITY 3 0.0001
937 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
938 ADVERSE DRUG REACTION 8 0.0001
939 CONVULSION 5 0.0001
940 DELIRIUM 3 0.0001
941 PULMONARY EMBOLISM 8 0.0001
942 CEREBRAL HAEMORRHAGE 3 0.0001
943 DIABETIC KETOACIDOSIS 2 0.0001
944 THERAPEUTIC RESPONSE DECREASED 5 0.0001
945 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
946 ACNE 6 0.0001
947 ABDOMINAL PAIN LOWER 2 0.0001
948 ILLNESS 8 0.0001
949 PLASMA CELL MYELOMA 3 0.0001
950 DEAFNESS 2 0.0001
951 DEVICE DIFFICULT TO USE 5 0.0001
952 MYOCARDIAL INFARCTION 13 0.0001
953 EXTRA DOSE ADMINISTERED 3 0.0001
954 ABNORMAL DREAMS 2 0.0001
955 MEDICATION ERROR 4 0.0001
956 DEVICE DISLOCATION 3 0.0001
957 LIVER DISORDER 3 0.0001
958 EPILEPSY 2 0.0001
959 ADVERSE EVENT 6 0.0001
960 RENAL DISORDER 3 0.0001
961 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
962 AGGRESSION 3 0.0001
963 ANGER 2 0.0001
964 HEPATIC ENZYME INCREASED 4 0.0001
965 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
966 DEVICE MALFUNCTION 4 0.0001
967 DEVICE ISSUE 5 0.0001
968 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
969 DRUG EFFECT INCOMPLETE 2 0.0001
970 CRYING 2 0.0001
971 PSORIASIS 7 0.0001
972 DYSARTHRIA 2 0.0001
973 INJECTION SITE PAIN 16 0.0001
974 DRUG INTOLERANCE 5 0.0001
975 INJECTION SITE BRUISING 4 0.0001
976 NO ADVERSE EVENT 9 0.0000
977 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
978 DRUG INTERACTION 7 0.0000
979 BREAST CANCER 4 0.0000
980 ARRHYTHMIA 2 0.0000
981 COMA 2 0.0000
982 INJECTION SITE ERYTHEMA 5 0.0000
983 DERMATITIS ATOPIC 2 0.0000
984 DRUG EFFECT DECREASED 2 0.0000
985 OVERDOSE 8 0.0000
986 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
987 DRUG ABUSE 3 0.0000
988 DRUG WITHDRAWAL SYNDROME 3 0.0000
989 DRUG DEPENDENCE 3 0.0000
990 TOXICITY TO VARIOUS AGENTS 3 0.0000